Clovis Oncology, Inc. Business Finance Contracts & Agreements

29 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated as of April 5, 2023, by and between Clovis Oncology, Inc. and pharma& Schweiz GmbH
Purchase Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2023
Pledge and Security Agreement, dated as of January 6, 2023, by and among the Company certain subsidiaries of the Company, as grantors, and the Administrative Agent
Security Agreements
Clovis Oncology, Inc.
Biotechnology
2023
Secured Superpriority Debtor-In-Possession Financing Agreement, dated as of January 6, 2023, by and among the Company, as borrower, Clovis Ireland and Clovis UK, as guarantors,...
Financing Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2023
DIP Term Sheet
Term Sheets
Clovis Oncology, Inc.
Biotechnology
NY
2022
Purchase and Assignment Agreement, dated as of December 11, 2022, by and between Clovis Oncology, Inc. and Novartis Innovative Therapies AG
Purchase Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2022
Clovis Oncology, Inc. 2021 Employee Stock Purchase Plan
Stock Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2021
Indenture, dated as of November 17, 2020, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2020
Form of Exchange and Purchase Agreement
Exchange Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2020
Form of Indenture, to be entered into by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2020
Underwriting Agreement, dated May 18, 2020
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2020
Indenture, dated as of August 13, 2019, by and between Clovis Oncology, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2019
Financing Agreement, dated as of May 1, 2019 among Clovis Oncology, Inc. (the Company), certain subsidiaries of the Company named therein, as Guarantors, the Lenders from time to...
Financing Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2019
Pledge and Security Agreement, dated as of May 1, 2019 among each of the Grantors party thereto and the Administrative Agent party thereto
Security Agreements
Clovis Oncology, Inc.
Biotechnology
2019
Clovis Oncology, Inc. 2011 Employee Stock Purchase Plan, as amended
Stock Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2018
First Supplemental Indenture, dated April 19, 2018
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2018
Indenture, dated April 19, 2018
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2018
Underwriting Agreement, dated April 16, 2018
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2018
Underwriting Agreement, dated April 16, 2018
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2018
CLOVIS ONCOLOGY, INC. 3,409,091Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2017
RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT
Stock Agreements
Clovis Oncology, Inc.
Biotechnology
2017
CLOVIS ONCOLOGY, INC. 5,000,000Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2017
CLOVISONCOLOGY, INC. 3,525,641 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2015
CLOVISONCOLOGY, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of September 9, 2014 2.50% Convertible Senior Notes due 2021 TABLE OF...
Indenture Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2014
CLOVISONCOLOGY, INC. 2,000,000 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Development and Commercialization Agreement by and...
Exchange Agreements
Clovis Oncology, Inc.
Biotechnology
CA
2013
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2013
STOCK PURCHASE AGREEMENT by and among CLOVISONCOLOGY, INC., EOS (ETHICAL ONCOLOGY SCIENCE) S.P.A., THE SELLERS LISTED ON EXHIBIT A HERETO, and SOFINNOVA CAPITALV FCPR, as the...
Stock Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2013
CLOVIS ONCOLOGY, INC. 3,333,334 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2013
CLOVIS ONCOLOGY, INC. [ ] Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2012